SCHEMBL6921062

SCHEMBL6921062

N#CCOc1cccc2c1c1cccc(F)c1n2Cc1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.39
TP53 P04637 1/20 0.39
PLA2G2A P14555 10/20 0.39
PLA2G10 O15496 3/20 0.39
PLA2G2E Q9NZK7 3/20 0.39
PLA2G1B P04054 2/20 0.39
PLA2G5 P39877 2/20 0.39
CYP19A1 P11511 1/20 0.38
HTT P42858 2/20 0.38
LMNA P02545 1/20 0.38
TSHR P16473 1/20 0.38
PLA2G2F Q9BZM2 2/20 0.37
PLA2G2D Q9UNK4 2/20 0.37
PLA2G6 O60733 1/20 0.37
PLA2G2C Q5R387 1/20 0.37
PLA2G12B Q9BX93 1/20 0.37
PLA2G12A Q9BZM1 1/20 0.37
PLA2G3 Q9NZ20 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6921541 0.84 HTR6 (0.47) MAPTTP53PLA2G2APLA2G10PLA2G2E
SCHEMBL6924339 0.78 DRD2 (0.46) MAPTTP53PLA2G2APLA2G10PLA2G2E
SCHEMBL6923666 0.76 KMT2A (0.44) MAPTPLA2G2APLA2G10PLA2G2EPLA2G1B
SCHEMBL6924122 0.75 PLA2G2A (0.46) MAPTTP53PLA2G2ACYP19A1HTT
SCHEMBL6919685 0.75 PLA2G2A (0.44) MAPTTP53PLA2G2APLA2G10HTT
SCHEMBL6924426 0.75 TSHR (0.47) MAPTPLA2G2APLA2G1BTSHRKMT2A
SCHEMBL6921487 0.72 ESR1 (0.43) MAPTTP53PLA2G2AHTTLMNA
SCHEMBL6926504 0.71 CYP19A1 (0.48) MAPTTP53CYP19A1LMNATSHR
SCHEMBL6921052 0.69 MEN1 (0.43) MAPTTP53PLA2G2AHTTLMNA
SCHEMBL6921144 0.69 CYP19A1 (0.53) PLA2G2APLA2G10PLA2G2EPLA2G1BPLA2G5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6514968-B1 Treating a disease or condition in a mammal wherein the 5-HT receptor is implicated and modulation of 5-HT function is desired comprising PHARMACIA & UPJOHN COMPANY 2003-02-04 US disclosed
EP-1210329-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2002-06-05 EP disclosed
WO-2001017963-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2001-03-15 WO disclosed